Chong Kun Dang Pharmaceutical Corp (185750):企業の財務・戦略的SWOT分析

◆英語タイトル:Chong Kun Dang Pharmaceutical Corp (185750) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C4817
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Chong Kun Dang Pharmaceutical Corp (185750) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Chong Kun Dang Pharmaceutical Corp (CKD Pharma) manufactures, distributes, imports and exports prescription drugs, active pharmaceutical ingredients (APIs), over-the-counter (OTC) drugs, health supplements and consumer health products. Its product portfolio includes prescription products for the entire segment and therapeutic classes; vitamins; shampoos; hair colors; aerosols; mat vaporizers and mosquito coils; and others. The company’s Chong Kun Dang Research Institute is characterized by three independent laboratories, namely, The New Drug Discovery Labs; The Technology Development Labs; and the Bio Research Labs. The company has presence in Korea, Japan, Vietnam and China. CKD Pharma is headquartered in Seoul, South Korea.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Chong Kun Dang Pharmaceutical Corp – Key Facts 5
Chong Kun Dang Pharmaceutical Corp – Key Employees 6
Chong Kun Dang Pharmaceutical Corp – Major Products and Services 7
Chong Kun Dang Pharmaceutical Corp – History 9
Chong Kun Dang Pharmaceutical Corp – Company Statement 13
Chong Kun Dang Pharmaceutical Corp – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
Chong Kun Dang Pharmaceutical Corp – Business Description 16
Chong Kun Dang Pharmaceutical Corp – SWOT Analysis 17
SWOT Analysis – Overview 17
Chong Kun Dang Pharmaceutical Corp – Strengths 17
Chong Kun Dang Pharmaceutical Corp – Weaknesses 18
Chong Kun Dang Pharmaceutical Corp – Opportunities 19
Chong Kun Dang Pharmaceutical Corp – Threats 20
Chong Kun Dang Pharmaceutical Corp – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Chong Kun Dang Pharmaceutical Corp, Recent Deals Summary 31
Section 5 – Appendix 32
Methodology 32
Ratio Definitions 32
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Chong Kun Dang Pharmaceutical Corp, Key Facts 5
Chong Kun Dang Pharmaceutical Corp, Key Employees 6
Chong Kun Dang Pharmaceutical Corp, Major Products and Services 7
Chong Kun Dang Pharmaceutical Corp, History 9
Chong Kun Dang Pharmaceutical Corp, Other Locations 14
Chong Kun Dang Pharmaceutical Corp, Key Competitors 21
Chong Kun Dang Pharmaceutical Corp, Ratios based on current share price 22
Chong Kun Dang Pharmaceutical Corp, Annual Ratios 23
Chong Kun Dang Pharmaceutical Corp, Annual Ratios (Cont...1) 24
Chong Kun Dang Pharmaceutical Corp, Annual Ratios (Cont...2) 25
Chong Kun Dang Pharmaceutical Corp, Interim Ratios 27
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Chong Kun Dang Pharmaceutical Corp, Recent Deals Summary 31
Currency Codes 32
Capital Market Ratios 32
Equity Ratios 33
Profitability Ratios 33
Cost Ratios 34
Liquidity Ratios 34
Leverage Ratios 35
Efficiency Ratios 35

List of Figures
Chong Kun Dang Pharmaceutical Corp, Performance Chart (2013 - 2017) 26
Chong Kun Dang Pharmaceutical Corp, Ratio Charts 28
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

★海外企業調査レポート[Chong Kun Dang Pharmaceutical Corp (185750):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BEKB | BCBE Private Banking:企業の戦略・SWOT・財務分析
    BEKB | BCBE Private Banking - Strategy, SWOT and Corporate Finance Report Summary BEKB | BCBE Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Harris Corp (HRS)-医療機器分野:企業M&A・提携分析
    Summary Harris Corp (Harris) is a communications and information technology company that offers communications products, services and systems, and network solutions. The company offers tactical and land mobile radio systems, IT services, clinically integrated solutions, managed services, government …
  • Krosaki Harima Corporation:企業の戦略・SWOT・財務情報
    Krosaki Harima Corporation - Strategy, SWOT and Corporate Finance Report Summary Krosaki Harima Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Oncor Electric Delivery Company LLC:電力:M&Aディール及び事業提携情報
    Summary Oncor Electric Delivery Company LLC (Oncor) a subsidiary of NextEra Energy, Inc., is a regulated electricity transmission and distribution company that operates distribution and transmission systems. It provides transmission grid connections to merchant generation facilities and interconnect …
  • Population Genetics Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Population Genetics Technologies Ltd (Population Genetics), a subsidiary of Agilent Technologies Inc is a biotechnology company. The company commercialize nucleic acid biochemistry tools and approaches. Its intellectual property assets include method for normalizing a nucleic acid sample, me …
  • Clinigen Group Plc (CLIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Clinigen Group Plc (Clinigen Group) is a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibativ. It off …
  • General Dynamics Corporation (GD):企業の財務・戦略的SWOT分析
    General Dynamics Corporation (GD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Localiza Rent A Car SA:企業の戦略・SWOT・財務情報
    Localiza Rent A Car SA - Strategy, SWOT and Corporate Finance Report Summary Localiza Rent A Car SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Avillion Berhad
    Avillion Berhad - Strategy, SWOT and Corporate Finance Report Summary Avillion Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ProterixBio Inc:医療機器:M&Aディール及び事業提携情報
    Summary ProterixBio Inc (ProterixBio), formerly BioScale Inc, is a medical device company that manufactures and markets ViBE platform products. The company offers ViBE platform, acoustic assays, ViBE software and custom assays, among others. Its ViBE platform enables non-optical detection and sensit …
  • Huber+Suhner AG (HUBN):企業の財務・戦略的SWOT分析
    Huber+Suhner AG (HUBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Prakash Constrowell Limited:企業の戦略・SWOT・財務分析
    Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report Summary Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Natural Alternatives International Inc (NAII):企業の財務・戦略的SWOT分析
    Summary Natural Alternatives International Inc (NAI) is a formulator and manufacturer of customized nutritional supplements. The company manufactures and distributes the only patented beta-alanine supplement on the market. It offers services such as science-based product formulation, raw material ac …
  • Hsh Nordbank Private Banking:企業の戦略・SWOT・財務分析
    Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report Summary Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Old Dominion Freight Line, Inc. (ODFL):企業の財務・戦略的SWOT分析
    Old Dominion Freight Line, Inc. (ODFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • MediPal Holdings Corp:企業の戦略・SWOT・財務情報
    MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SoftTech Yazılım Teknolojileri Arastırma Gelistirme ve Pazarlama Ticaret A.S.:企業の戦略・SWOT・財務情報
    SoftTech Yazılım Teknolojileri Arastırma Gelistirme ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary SoftTech Yazılım Teknolojileri Arastırma Gelistirme ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data a …
  • Essentra Plc (ESNT):企業の財務・戦略的SWOT分析
    Essentra Plc (ESNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Bluefish Pharmaceuticals AB-製薬・医療分野:企業M&A・提携分析
    Summary Bluefish Pharmaceuticals AB (Bluefish Pharmaceuticals) is a manufacturer and distributor of generic pharmaceutical products. The company provides products for various therapeutic areas including cardiovascular, the central nervous system, gastrointestinal, diabetes, oncology, dermatology, re …
  • Bajaj Allianz General Insurance Company Limited:企業の戦略・SWOT・財務分析
    Bajaj Allianz General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Allianz General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆